136 related articles for article (PubMed ID: 11352814)
1. Regulation of hepatic eNOS by caveolin and calmodulin after bile duct ligation in rats.
Shah V; Cao S; Hendrickson H; Yao J; Katusic ZS
Am J Physiol Gastrointest Liver Physiol; 2001 Jun; 280(6):G1209-16. PubMed ID: 11352814
[TBL] [Abstract][Full Text] [Related]
2. Influence of caveolin on constitutively activated recombinant eNOS: insights into eNOS dysfunction in BDL rat liver.
Hendrickson H; Chatterjee S; Cao S; Morales Ruiz M; Sessa WC; Shah V
Am J Physiol Gastrointest Liver Physiol; 2003 Sep; 285(3):G652-60. PubMed ID: 12829439
[TBL] [Abstract][Full Text] [Related]
3. Effect of chronic ethanol administration on hepatic eNOS activity and its association with caveolin-1 and calmodulin in female rats.
Wang X; Abdel-Rahman AA
Am J Physiol Gastrointest Liver Physiol; 2005 Sep; 289(3):G579-85. PubMed ID: 15845868
[TBL] [Abstract][Full Text] [Related]
4. Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat.
Shah V; Toruner M; Haddad F; Cadelina G; Papapetropoulos A; Choo K; Sessa WC; Groszmann RJ
Gastroenterology; 1999 Nov; 117(5):1222-8. PubMed ID: 10535886
[TBL] [Abstract][Full Text] [Related]
5. Endothelial nitric oxide synthase and caveolin-1 are co-localized in sinusoidal endothelial fenestrae.
Yokomori H; Oda M; Ogi M; Kamegaya Y; Tsukada N; Ishii H
Liver; 2001 Jun; 21(3):198-206. PubMed ID: 11422783
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of endothelial nitric oxide synthase and caveolin-1 in human cirrhosis.
Yokomori H; Oda M; Ogi M; Sakai K; Ishii H
Liver; 2002 Apr; 22(2):150-8. PubMed ID: 12028410
[TBL] [Abstract][Full Text] [Related]
7. Elevated expression of caveolin-1 at protein and mRNA level in human cirrhotic liver: relation with nitric oxide.
Yokomori H; Oda M; Yoshimura K; Nomura M; Wakabayashi G; Kitajima M; Ishii H
J Gastroenterol; 2003; 38(9):854-60. PubMed ID: 14564631
[TBL] [Abstract][Full Text] [Related]
8. [The roles of caveolin-1 and endothelial nitric oxide synthase in the development of portal hypertension in rats with liver cirrhosis].
Xu B; Zhu GH; Weng JF; Cai WS; Xia JT; Li SH
Zhonghua Gan Zang Bing Za Zhi; 2008 Mar; 16(3):184-7. PubMed ID: 18364076
[TBL] [Abstract][Full Text] [Related]
9. Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride-induced rat liver cirrhotic model.
Sakamoto M; Nakamura T; Torimura T; Iwamoto H; Masuda H; Koga H; Abe M; Hashimoto O; Ueno T; Sata M
J Gastroenterol Hepatol; 2013 Jan; 28(1):168-78. PubMed ID: 22849788
[TBL] [Abstract][Full Text] [Related]
10. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension.
Rockey DC; Chung JJ
Gastroenterology; 1998 Feb; 114(2):344-51. PubMed ID: 9453496
[TBL] [Abstract][Full Text] [Related]
11. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase.
Feron O; Dessy C; Moniotte S; Desager JP; Balligand JL
J Clin Invest; 1999 Mar; 103(6):897-905. PubMed ID: 10079111
[TBL] [Abstract][Full Text] [Related]
12. Chronic administration of aminoguanidine reduces vascular nitric oxide production and attenuates liver damage in bile duct-ligated rats.
Wei CL; Hon WM; Lee KH; Khoo HE
Liver Int; 2005 Jun; 25(3):647-56. PubMed ID: 15910502
[TBL] [Abstract][Full Text] [Related]
13. Opposite regulation of endothelial NO synthase by HSP90 and caveolin in liver and lungs of rats with hepatopulmonary syndrome.
Frossard JL; Schiffer E; Cikirikcioglu B; Bourquin J; Morel DR; Pastor CM
Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G864-70. PubMed ID: 17921448
[TBL] [Abstract][Full Text] [Related]
14. Sequential changes in redox status and nitric oxide synthases expression in the liver after bile duct ligation.
Vázquez-Gil MJ; Mesonero MJ; Flores O; Criado M; Hidalgo F; Arévalo MA; Sánchez-Rodríguez A; Tuñón MJ; López-Novoa JM; Esteller A
Life Sci; 2004 Jun; 75(6):717-32. PubMed ID: 15172180
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide synthase 1 is partly compensating for nitric oxide synthase 3 deficiency in nitric oxide synthase 3 knock-out mice and is elevated in murine and human cirrhosis.
Biecker E; Neef M; Sägesser H; Shaw S; Koshy A; Reichen J
Liver Int; 2004 Aug; 24(4):345-53. PubMed ID: 15287858
[TBL] [Abstract][Full Text] [Related]
16. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
Rosado E; Rodríguez-Vilarrupla A; Gracia-Sancho J; Tripathi D; García-Calderó H; Bosch J; García-Pagán JC
Hepatology; 2013 Oct; 58(4):1424-35. PubMed ID: 23703868
[TBL] [Abstract][Full Text] [Related]
17. A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis.
Laleman W; Omasta A; Van de Casteele M; Zeegers M; Vander Elst I; Van Landeghem L; Severi T; van Pelt J; Roskams T; Fevery J; Nevens F
Hepatology; 2005 Dec; 42(6):1382-90. PubMed ID: 16317694
[TBL] [Abstract][Full Text] [Related]
18. Differential expression and localization of nitric oxide synthases in cirrhotic livers of bile duct-ligated rats.
Wei CL; Khoo HE; Lee KH; Hon WM
Nitric Oxide; 2002 Sep; 7(2):91-102. PubMed ID: 12223178
[TBL] [Abstract][Full Text] [Related]
19. Regulatory mechanisms of hepatic microcirculation.
Oda M; Yokomori H; Han JY
Clin Hemorheol Microcirc; 2003; 29(3-4):167-82. PubMed ID: 14724338
[TBL] [Abstract][Full Text] [Related]
20. Role of thromboxane A2 in early BDL-induced portal hypertension.
Yokoyama Y; Xu H; Kresge N; Keller S; Sarmadi AH; Baveja R; Clemens MG; Zhang JX
Am J Physiol Gastrointest Liver Physiol; 2003 Mar; 284(3):G453-60. PubMed ID: 12431905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
